These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36067)

  • 41. What you thought you knew about motion sickness isn't necessarily so.
    Cowings PS; Malmstrom FV
    Flying Saf; 1984 Feb; 40(2):12-7. PubMed ID: 11540877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elicitation of motion sickness by head movements in the microgravity phase of parabolic flight maneuvers.
    Lackner JR; Graybiel A
    Aviat Space Environ Med; 1984 Jun; 55(6):513-20. PubMed ID: 6466247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vestibular response to pseudorandom angular velocity input: progress report.
    Lessard CS; Wong WC
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A203-6. PubMed ID: 3499893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [An experimental validation of pharmacological agents to arrest the vestibulo-autonomic syndrome (motion sickness)].
    Shashkov VS; Kotovskaia AR; Orlov OI; Koloteva MI; Shashkov AV; Karsanova SK
    Eksp Klin Farmakol; 1999; 62(6):11-5. PubMed ID: 10650518
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.
    Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM
    Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of proposed preflight adaptation training on eye movements, self-motion perception, and motion sickness: a progress report.
    Parker DE; Reschke MF; von Gierke HE; Lessard CS
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A42-9. PubMed ID: 3675503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diazepam as an anti-motion sickness drug.
    McClure JA; Lycett P; Baskerville JC
    J Otolaryngol; 1982 Aug; 11(4):253-9. PubMed ID: 7131636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. McGill-trained MD, experiment give June 20 shuttle flight strong Canadian flavour.
    Thirsk R
    CMAJ; 1996 Jun; 154(12):1884-8. PubMed ID: 8653649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of transdermally administered scopolamine in preventing motion sickness.
    McCauley ME; Royal JW; Shaw JE; Schmitt LG
    Aviat Space Environ Med; 1979 Nov; 50(11):1108-11. PubMed ID: 393242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sudden emesis following parabolic flight maneuvers: implications for space motion sickness.
    Lackner JR; Graybiel A
    Aviat Space Environ Med; 1986 Apr; 57(4):343-7. PubMed ID: 3485969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus.
    Pyykkö I; Padoan S; Schalén L; Lyttkens L; Magnusson M; Henriksson NG
    Aviat Space Environ Med; 1985 Aug; 56(8):777-82. PubMed ID: 3929760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimotion sickness and antiemetic drugs.
    Wood CD
    Drugs; 1979 Jun; 17(6):471-9. PubMed ID: 467277
    [No Abstract]   [Full Text] [Related]  

  • 53. [Evaluation of the effectiveness of drugs for prevention of motion sickness].
    Galle RR; Gusakova GA; Sabaev VV; Galle NN
    Kosm Biol Aviakosm Med; 1988; 22(4):90-4. PubMed ID: 3066982
    [No Abstract]   [Full Text] [Related]  

  • 54. Effectiveness and duration of intramuscular antimotion sickness medications.
    Wood CD; Stewart JJ; Wood MJ; Mims M
    J Clin Pharmacol; 1992 Nov; 32(11):1008-12. PubMed ID: 1474161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autogenic-feedback training exercise is superior to promethazine for control of motion sickness symptoms.
    Cowings PS; Toscano WB
    J Clin Pharmacol; 2000 Oct; 40(10):1154-65. PubMed ID: 11028255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Space motion sickness and space vestibulology.
    Igarashi M; Kobayashi K
    J UOEH; 1985 Mar; 7 Suppl():228-36. PubMed ID: 3874411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vestibular suppression during space flight.
    Watt D; Lefebvre L
    J Vestib Res; 2003; 13(4-6):363-76. PubMed ID: 15096678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A cholinomimetic model of motion sickness and space adaptation syndrome.
    Janowsky DS; Risch SC; Ziegler M; Kennedy B; Huey L
    Aviat Space Environ Med; 1984 Aug; 55(8):692-6. PubMed ID: 6487203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Motion sickness--causes, symptoms, therapy].
    von Baumgarten R; Reiser M
    Verh Dtsch Ges Inn Med; 1989; 95():593-7. PubMed ID: 2690530
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of some motion sickness suppressants on static and dynamic tracking performance.
    Schroeder DJ; Collins WE; Elam GW
    Aviat Space Environ Med; 1985 Apr; 56(4):344-50. PubMed ID: 3994616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.